BCEL — Atreca Share News
0.000.00%
Last trade - 00:00Brief: Atreca Announces FDA Clearance Of Investigational New Drug Application For ATRC-101
Brief: Atreca Reports Third Quarter 2019 Financial Results
U.S. STOCKS ON THE MOVE-Foot Locker, HP, Gap, VMware, Salesforce
Brief: Atreca Announces Second Quarter Net Loss Per Share, Basic And Diluted $3.67
Brief: Wellington Management Company LLP Reports 16.23% Passive Stake In Atreca Inc As Of June 28
Brief: Boxer Capital Reports 8.3% Passive Stake In Atreca As Of June 24 - SEC Filing
Livongo Health joins 2019 IPO boom
Adaptive doubles, BridgeBio surges amid biotech IPO parade
Brief: Redmile Group Reports 5.5% Passive Stake In Atreca As Of June 24
Brief: Atreca Shares Open 17% Above IPO Price In Debut
NASDAQ RESUMED
NASDAQ TRADE HALT REASON NOT AVAILABLE
Brief: Atreca Announces Pricing Of Initial Public Offering